Celgene Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (73)

Latest Posts

About This Stock More About This Stock
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By: ChinaBio® Today
Saturday, January 20, 2018 5:34 PM EST
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
In this article: JNJ, LLY, CELG, BGNE, MRTX, AMRN
Read
JPMorgan Healthcare Day One Notes: Weak Start Despite Positive Updates
Article By: Rod Raynovich
Tuesday, January 9, 2018 2:59 PM EST
Biotech stocks abruptly sold off at the market open yesterday with the XBI down 2% to the $85.31 level and the IBB down 1.33% to $108.37.
In this article: IBB, XBI, BIIB, CELG, GILD
Read
A Dividend Growth Investor’s Perspective On Non-Dividend Stocks
Article By: SureDividend
Monday, January 8, 2018 11:18 AM EST
Without a doubt, dividends and the compounding associated with re-investing them over the long-term is one of, if not the most powerful force in the markets. However, this success has become a bit of a double-edged sword in recent years.
In this article: AMD, FDX, V, TCEHY, AMZN, ATVI, CELG, EXPE, NVDA, BABA, FB, GOOGL, JD, BRK-B, MA, NKE, SBUX
Read
Celgene To Acquire Impact Biomedicines, Adds Fedratinib To Pipeline
Article By: The Fly
Sunday, January 7, 2018 10:09 PM EST
Under the terms of the agreement, Celgene will pay approximately $1.1B upfront and up to $1.25B in contingent payments based on regulatory approval milestones for myelofibrosis.
In this article: CELG
Read
Week In Review: Nearly $2 Billion Late-December Week For China Pharma Deals
Article By: ChinaBio® Today
Saturday, December 23, 2017 5:37 PM EST
Nanjing Legend Biotech and Janssen Biotech will form a global partnership with Legend for its CAR-T candidate and Crown Bioscience, a CRO with facilities in China, Taiwan, US and Europe, will be acquired for $400 million by JSR Corporation of Japan.
In this article: AVEO, CELG, FPRX, TRXC, BGNE, VTVT, ZLAB
Read

PARTNER HEADLINES

Latest Tweets for $CELG

No tweets yet!